| Phase 3 |
| NCT07816380 |
A Phase III Study to Evaluate the Efficacy and Safety of JYP0322 in Previously Untreated… |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Not Yet Recruiting |
2026-09-22 |
| NCT07154368 |
JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously… |
Non Small Cell Lung Cancer |
Not Yet Recruiting |
2025-09-19 |
| Phase 2/3 |
| NCT06125327 |
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis… |
Idiopathic Pulmonary Fibrosis |
Recruiting |
2024-11-19 |
| Phase 2 |
| NCT06895031 |
Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in… |
Solid Tumor |
Recruiting |
2026-03-06 |
| NCT06697535 |
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute… |
Neuromyelitis Optica Spectrum Disorders |
Recruiting |
2024-11-20 |
| NCT07843290 |
A Study of JYP0066 Cream in Mild-to-Moderate Atopic Dermatitis |
Atopic Dermatitis (AD) |
Not Yet Recruiting |
2026-09-30 |
| NCT06158490 |
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis |
Moderate-to-severe Atopic Dermatitis |
Enrolling by Invitation |
2025-03-20 |
| Phase 1 |
| NCT06128148 |
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors |
Protein Kinase Inhibitors |
Recruiting |
2025-07-14 |